Chondromodulin-I maintains normal cardiac valves by preventing angiogensis

Daihiko Hakuno, Naritaka Kimura, Masatoyo Yoshioka, Keiichi Fukuda

Research output: Contribution to journalReview articlepeer-review


We recently identified chondromodulin-I as a crucial antiangiogenic factor for maintaining cardiac valvular function. Normally, avascular cardiac valves from ApoE-/- mice and humans with valvular heart disease showed angiogenesis and increased expression of vascular endothelial cell growth factor and matrix metalloproteinases, with downregulation of chondromodulin-I. Conditioned medium from cultured valvular interstitial cells inhibited tube formation and migration of endothelial cells, and this effect was rescued by chondromodulin-I siRNA. Cardiac valves of chondromodulin-I-knockout mice showed neovascularization, lipid deposition and calcification, indicating early aortic stenosis. These findings implicated chondromodulin-I as a critical factor for maintaining normal cardiac valves by preventing angiogenesis.

Original languageEnglish
Pages (from-to)177-184
Number of pages8
JournalDrug Discovery Today: Disease Models
Issue number4
Publication statusPublished - 2007 Dec

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Chondromodulin-I maintains normal cardiac valves by preventing angiogensis'. Together they form a unique fingerprint.

Cite this